Find News

Filter articles

Applied Filters

Showing 101 to 110 of 121 results

Biotech industry reacts to USPTO’s Myriad/Mayo guidelines

Australia, EU, Japan, UK, US13-08-2014

A group of 12 international biotechnology associations has written to the US Patent and Trademark Office (USPTO), raising concerns about the office’s guidelines on determining the patent eligibility of natural products in the aftermath of the Myriad and Mayo cases.

NeuClone and Serum Institute collaborate on biosimilars

Australia, India08-07-2014

Australian biotechnology company NeuClone has signed an agreement with vaccine maker the Serum Institute of India to manufacture and supply ten biosimilar monoclonal antibody drugs around the world.

MMR Global and Claydata enter into licensing agreement


Personal health records company MMR Global has entered into a licensing agreement with Australian medical database company Claydata.

Canada and Australia in new stem cell partnership

Australia, Canada16-06-2014

Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries.

Gilead’s attempt to patent Sovaldi in India opposed

India, US26-03-2014

Gilead Sciences has received another challenge to its application to patent its new hepatitis C drug Sovaldi (sofosbuvir) in India.

Vaccine maker KAEL-GemVax appoints CPA Global as IP specialist

South Korea13-03-2014

South Korean cancer vaccine maker KAEL-GemVax has appointed CPA Global as its IP management specialist.

Pfizer Australia faces antitrust accusations


Australia’s antitrust regulator has launched proceedings against Pfizer’s Australian arm, accusing it of abusing its power when supplying cholesterol-lowering drug atorvastatin to pharmacies.

Australian High Court says medical treatment methods are patentable


The High Court in Australia has said for the first time that a method of medical treatment for the human body can be a patentable invention.

Takeda announces new COO


Takeda has announced that Christophe Weber, a member of GlaxoSmithKline’s global corporate executive team, will be joining the company as chief operating officer by April next year.

US reveals changes in TPP drug policy


The US government has said it is now advocating a “differential” approach to policies on patenting drugs as part of continuing trade negotiations with Pacific countries.

Showing 101 to 110 of 121 results